Schrodinger Inc. (SDGR) Financial Statements (2025 and earlier)

Company Profile

Business Address 1540 BROADWAY
NEW YORK, NY 10036
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments377,289431,079463,003496,283548,673527,688
Cash and cash equivalents108,109130,236155,315249,378285,963233,206
Short-term investments269,180300,843307,688246,905262,710294,482
Restricted cash and investments4,2274,6385,7516,2305,0534,486
Receivables11,84919,83965,99219,8849,65246,691
Prepaid expense15,49312,3499,92613,11113,99911,396
Other undisclosed current assets40,32125,78123,12412,25314,58513,473
Total current assets:449,179493,686567,796547,761591,962603,734
Noncurrent Assets
Operating lease, right-of-use asset116,525118,578117,778119,822112,984105,982
Property, plant and equipment   (18,150)22,49820,35316,493
Long-term investments and receivables88,55591,38783,25191,863106,404101,539
Long-term investments88,55591,38783,25191,863106,404101,539
Intangible assets, net (including goodwill)4,7914,7914,7914,7914,7914,791
Goodwill4,7914,7914,7914,7914,7914,791
Other noncurrent assets3,5983,1876,0147,4135,0726,234
Other undisclosed noncurrent assets25,72326,13341,475   
Total noncurrent assets:239,192244,076235,159246,387249,604235,039
TOTAL ASSETS:688,371737,762802,955794,148841,566838,773
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities42,15940,08360,57445,44646,20760,019
Accounts payable8,1169,97416,81510,31812,42811,987
Accrued liabilities34,04330,10943,75935,12833,77948,032
Deferred revenue40,79949,49756,23143,31346,67451,578
Other undisclosed current liabilities16,80116,92716,86816,27913,92111,810
Total current liabilities:99,759106,507133,673105,038106,802123,407
Noncurrent Liabilities
Liabilities, other than long-term debt114,632117,549120,724125,529123,539125,106
Deferred revenue7,0808,0169,04312,10215,62020,348
Other liabilities424545667707600700
Operating lease, liability107,128108,988111,014112,720107,319104,058
Total noncurrent liabilities:114,632117,549120,724125,529123,539125,106
Total liabilities:214,391224,056254,397230,567230,341248,513
Equity
Equity, attributable to parent, including:473,980513,706548,558563,581611,225590,260
Additional paid in capital920,621906,193885,973871,100856,913840,446
Accumulated other comprehensive income (loss)(180)(72)281(491)(683)(899)
Accumulated deficit(447,189)(393,142)(338,418)(307,748)(245,724)(250,002)
Other undisclosed equity, attributable to parent728727722720719715
Total equity:473,980513,706548,558563,581611,225590,260
TOTAL LIABILITIES AND EQUITY:688,371737,762802,955794,148841,566838,773

Income Statement (P&L) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Revenues47,33436,59874,12642,56940,65464,782
Gain (loss) on disposition of assets for financial service operations(5,833)8,13785,344(14,522)40,65435,737
Cost of revenue(15,999)(17,708)(16,576)(18,930)(21,379)(19,089)
Other undisclosed gross profit     (5,465) 
Gross profit:31,33518,89057,55023,63913,81045,693
Operating expenses(84,064)(86,323)(87,171)(79,832)(74,943)(76,194)
Operating loss:(52,729)(67,433)(29,621)(56,193)(61,133)(30,501)
Nonoperating income (expense)(1,235)13,165(1,891)(8,718)44,980185,996
Other nonoperating income4,5985,0286,6265,8044,3262,937
Income (loss) from continuing operations before equity method investments, income taxes:(53,964)(54,268)(31,512)(64,911)(16,153)155,495
Income from equity method investments   147,213   
Other undisclosed loss from continuing operations before income taxes   (147,213)   
Income (loss) from continuing operations before income taxes:(53,964)(54,268)(31,512)(64,911)(16,153)155,495
Income tax expense (benefit)(83)(456)8422,88720,431(26,359)
Net income (loss) available to common stockholders, diluted:(54,047)(54,724)(30,670)(62,024)4,278129,136

Comprehensive Income ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Net income (loss):(54,047)(54,724)(30,670)(62,024)4,278129,136
Comprehensive income (loss):(54,047)(54,724)(30,670)(62,024)4,278129,136
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(108)(353)7721922161,483
Comprehensive income (loss), net of tax, attributable to parent:(54,155)(55,077)(29,898)(61,832)4,494130,619

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: